Ongeno

Kraków, Poland

Ongeno is a medical technology developer that specializes in the development of treatments for a variety of autoimmune diseases.

$3.6M raised

Jan 2025

Undisclosed

30,000+ verified contacts

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Ongeno

How much funding has Ongeno raised?

Ongeno has raised $3.6M in total funding. The most recent round was Undisclosed. The last funding was announced in January 2025.

Where is Ongeno headquartered?

Ongeno is headquartered in Kraków, Poland.

What does Ongeno do?

Ongeno is a medical technology developer that specializes in the development of treatments for a variety of autoimmune diseases.

What stage is Ongeno at?

Ongeno is at the Undisclosed stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated January 21, 2025.

MLA

"Ongeno — Funding & Investors." VCBacked, January 21, 2025, https://www.vcbacked.co/company/ongeno. Accessed July 4, 2026.

APA

VCBacked. (2025). Ongeno — Funding & Investors. Retrieved July 4, 2026, from https://www.vcbacked.co/company/ongeno

Wikipedia (cite web)

{{cite web |title=Ongeno — Funding & Investors |url=https://www.vcbacked.co/company/ongeno |website=VCBacked |access-date=July 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated January 21, 2025.